MKI67 and glioblastoma: Further evaluation of Ki-67, the nuclear antigen marker for active cell proliferation, revealed its strongly diminished presence in the WHI-P131- and PF-956980-treated GBM cells compared with the untreated control cells 24 h after culture (Figure 2c).